Navigation Links
'AIDS is DC's Katrina' Ad Challenges Obama to Act on U.S. Epidemic
Date:6/2/2009

>

WHAT: Press Teleconference -- AHF launches TV, internet ad urging action on AIDS

WHEN: Wednesday, June 3rd 2009 -- 11:30 a.m. Eastern (1100), 8:30 a.m. Pacific (0800)

HOW: Teleconference Dial in information, +1.877.411.9748 participant code #7931503

WHO: Michael Weinstein, AIDS Healthcare Foundation President; Tom Myers, AIDS Healthcare Foundation Chief of Public Affairs & General Counsel

"Katrina quickly came to symbolize the Bush Administration's neglect and indifference of some of America's most vulnerable citizens. Today, 56,000 new HIV infections each year in the U.S., a 40% increase from last year, symbolize neglect and indifference -- and the failure of our U.S. HIV prevention efforts," said Michael Weinstein, President of AIDS Healthcare Foundation. "The fact that Washington DC's HIV prevalence rate is now higher than some hard-hit African countries is an indictment of how the CDC has failed to lead in HIV prevention efforts. When this news about Washington's HIV rate first broke in March, President Obama remained silent. Despite his silence on AIDS to date, we hope this ad will prod President Obama to act forcefully on AIDS, and we remain hopeful he will be the change that we can believe in -- and urgently need -- on AIDS."

Many AIDS and public health officials believe that the 3% HIV prevalence rate recently reported in Washington is actually a low estimate; the true figure, they believe, may be closer to 5% of the District's population. Some fault ineffective leadership in Washington and the CDC for the burgeoning domestic AIDS epidemic, which is now disproportionately affecting minorities, people in rural areas and throughout the South. To address the growing epidemic, the CDC issued revised guidelines for HIV testing in September of 2006. It its revised guidel
'/>"/>

SOURCE AIDS Healthcare Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. New Drug Aids Muscle Function in Myasthenia Gravis
3. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
4. Link Uncovered Between Benign Prostatic Hyperplasia and NSAIDs, Says Harvard Mens Health Watch
5. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
8. Tulane University to receive $14M for international HIV/AIDS program
9. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
10. Global Health Project targets reducing AIDS among Indias adolescents
11. Local Artists Unite in the Fight Against AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... The news about youth and diabetes keeps getting worse. ... that children who develop Type 2 diabetes are at high ... at a higher rate than people who acquire Type 2 ... 2 diabetes, they seem to be at very high risk ... M.D., professor of pediatric endocrinology in the School of Medicine ...
(Date:5/24/2013)... 2013 Fit Yummy Mummy, a fitness ... who are trying to get rid of the belly ... ideal for women who want to combine exercises with ... ’s Stan Stevenson, prompting an investigative review. , “Holly's ... a wide variety of motivational strategies, nutritional plans, proper ...
(Date:5/24/2013)... The Institute for Integrative Nutrition , the ... has donated $10,000 to the Cleveland Courage Fund , ... Ohio. , “When the news came out on Monday, May ... and her daughter had escaped from a Cleveland home after ... horrified,” said Integrative Nutrition Founder, Director, and Primary Teacher Joshua ...
(Date:5/24/2013)... 2013 General Data Company Inc., ... tracking and data management products and solutions, has ... Inc., (TBS) of Durham, North Carolina, a leading ... for the clinical and research pathology marketplace. TBS ... which provides specialty products and solutions to hospitals, ...
(Date:5/24/2013)... Finding the answer for this is at the centre of ... the Bergen fMRI Group at the University of Bergen (UiB) ... The way they do this is by studying people who ... mental illness. For a five-year period, the group is studying ... report published in Frontiers in Human Neuroscience shows ...
Breaking Medicine News(10 mins):Health News:Youth with type 2 diabetes at much higher risk for heart, kidney disease 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2Health News:Integrative Nutrition Donates $10,000 to the Cleveland Courage Fund 2Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3Health News:Help at hand for schizophrenics 2
... the 13th time, more than any hospital in the U.S. , ... ... (NorthShore) was named one of the nation,s 100 Top Hospitals® by Thomson ... and quality of healthcare. NorthShore has been named a Top 100 Hospital ...
... (April 1, 2009) It appears that a drug ... similar effect on the compulsive behavior of kleptomaniacs it ... the University of Minnesota., The Medical School,s Department of Psychiatry ... ages 17-75, who spent an average of at least one ...
... KUALA LUMPUR, Malaysia, March 31 Rheumatoid arthritis (RA) ... which the body,s defense system attacks the joints through ... lines and lubricates the joints. The most visible symptoms ... of the hands and feet. It can cause fatigue, ...
... LifeCare Holdings, Inc. (the "Company") today announced its operating ... 2008. Three Months Ended December 31, 2008 ... service revenue of $94.2 million for the three months ended ... the same period in 2007 while patient days were unchanged. ...
... Guideline Reached For Quantitative Polymerase Chain ReactionSALT LAKE CITY, ... and the American Association for Clinical Chemistry ... for a key laboratory method called qPCR (or quantitative ... international scientists representing the medical and research fields. qPCR ...
... The U.S. District Court for the District of ... between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. ... markets CONCERTA(R) (methylphenidate HCI) Extended-Release Tablets CII, said the ... valid or infringed by the filing of Andrx,s Abbreviated ...
Cached Medicine News:Health News:NorthShore University HealthSystem Named One of the Nation's Top 100 Hospitals by Thomson Reuters 2Health News:NorthShore University HealthSystem Named One of the Nation's Top 100 Hospitals by Thomson Reuters 3Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 2Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 3Health News:LifeCare Holdings, Inc. Announces Year-End Results 2Health News:LifeCare Holdings, Inc. Announces Year-End Results 3Health News:LifeCare Holdings, Inc. Announces Year-End Results 4Health News:LifeCare Holdings, Inc. Announces Year-End Results 5Health News:LifeCare Holdings, Inc. Announces Year-End Results 6Health News:LifeCare Holdings, Inc. Announces Year-End Results 7Health News:LifeCare Holdings, Inc. Announces Year-End Results 8Health News:LifeCare Holdings, Inc. Announces Year-End Results 9Health News:LifeCare Holdings, Inc. Announces Year-End Results 10Health News:LifeCare Holdings, Inc. Announces Year-End Results 11Health News:LifeCare Holdings, Inc. Announces Year-End Results 12Health News:LifeCare Holdings, Inc. Announces Year-End Results 13Health News:LifeCare Holdings, Inc. Announces Year-End Results 14Health News:LifeCare Holdings, Inc. Announces Year-End Results 15Health News:International Scientists Secure Quality in Molecular Diagnostics 2Health News:International Scientists Secure Quality in Molecular Diagnostics 3Health News:District Court Decision Received in CONCERTA(R) Patent Case 2Health News:District Court Decision Received in CONCERTA(R) Patent Case 3
(Date:5/24/2013)... LOS ANGELES , May 24, 2013  An ... gathered on Saturday, May 18, in Santa ... findings on new lung-sparing therapies for MPM, a rare ... and commonly affects the pleura, the lining of the ... Heart, Lung and Blood Institute, the 3rd Annual International ...
(Date:5/24/2013)... May 24, 2013 In accordance with Rule 17.1 ... 14e-1 of the United States Exchange Act, Echo Pharma Acquisition ... for Elan Corporation (NYSE: ELN). Background ... made an offer for the entire of the issued and ... (the "Original Offer").  On 20 May 2013, ...
(Date:5/23/2013)... 24, 2013 3SBio Inc. (NASDAQ: ... leading China -based biotechnology company ... products, announced today that, at an extraordinary general ... voted in favor of the proposal to authorize ... of merger dated February 8, 2013, among Decade ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 93SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... 16, 2011 Cancer patients in China ... the announcement that a leading cancer center is acquiring ... VAR). This device is the first high dose rate ... leader in radiotherapy systems. Jilin University ...
... 16, 2011 U L ... announced today that it has filed an abbreviated 510(k) application ... label claim to include the management and mitigation of pain. ... a randomized clinical study comparing Altrazeal® to Acquacel® Ag in ...
Cached Medicine Technology:First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital 2ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 2ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 3ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 4
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoScrew is a unipolar permanent pacing lead with a fixed screw a double flanch for permanent pacing. Due to latest technologies, VascoScrew D10/60 M is compatible to all pacemaker-cavities with th...
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
Medicine Products: